INTRODUCTION
============

Esophageal variceal hemorrhage has a significant impact on mortality and morbidity in patients with cirrhosis and results in considerable burdens on healthcare resources \[[@b1-ce-2019-094]-[@b3-ce-2019-094]\]. Over the last decade, several clinical and epidemiological factors were reported to impact the outcome of esophageal variceal bleeding, including the presence of an underlying malignancy, the etiology and severity of cirrhosis, and hospital characteristics such as hospital volume \[[@b3-ce-2019-094]-[@b6-ce-2019-094]\]. Recently, the effects of various environmental factors on the disease patterns of gastrointestinal disorders were explored \[[@b7-ce-2019-094],[@b8-ce-2019-094]\]. A seasonal periodicity in upper gastrointestinal bleeding was reported, particularly for peptic ulcer diseases. However, the underlying basis for such variation was unclear and whether esophageal variceal bleeding rates also varied with seasonal change was not well described \[[@b8-ce-2019-094]-[@b10-ce-2019-094]\]. Therefore, the current study aimed to assess whether seasonal and monthly variations exist with regard to the hospitalizations and outcomes of esophageal variceal hemorrhage.

MATERIALS AND METHODS
=====================

Data source
-----------

We obtained data from the Nationwide Inpatient Sample (NIS) database, which is the largest openly accessible all-payer inpatient healthcare database in the United States. The NIS database was created by the Healthcare Cost and Utilization Project (HCUP) and is used to frame health policies at the federal, state, and county levels. The HCUP is a program developed by the Agency for Healthcare Research and Quality. It comprises de-identified hospitalization records for more than 7 million unweighted annual hospital stays and 35 million weighted annual hospitalizations in the US. The NIS records 7--8 million hospitalizations annually. The data were sampled from approximately 4,411 hospitals and 45 states throughout the US. We used data from 2005 to 2014.

Study population
----------------

Patients in our sample were selected based on International Classification of Diseases, Clinical Modification- 9th Revision (ICD-9-CM) codes. We identified cases hospitalized with primary or secondary discharge diagnoses of esophageal varices with hemorrhage. We excluded cases lacking information on in-hospital mortality or month of hospitalization. The final study sample consisted of all adult hospitalizations with a discharge diagnosis of esophageal varices with hemorrhage (ICD-9-CM codes 456.0 and 456.20) as previously described \[[@b3-ce-2019-094],[@b11-ce-2019-094]\]. A flow diagram of case selection is shown in [Fig. 1](#f1-ce-2019-094){ref-type="fig"}.

Study outcomes and variables
----------------------------

The primary outcome measure for this study was a comparison of the frequency of hospitalizations by each month of the year. For January, March, May, July, August, October, and December, calculations were based on a 31-day month; while for April, June, September, and November calculations were based on a 30-day month. For February, we calculated 29 days for two leap years and 28 days for each month for the other eight years. The secondary outcome measure was the rate of in-hospital mortality associated with esophageal varices bleeding. We also analyzed the admission and in-hospital mortality rates for each geographic region in the US; namely, the Northeastern, Midwestern, Southern, and Western regions. We estimated the differences in resource utilization for each month by calculating the length of stay and hospital costs of care. Potential confounders and covariates including age, sex, race, comorbidities (with Elixhauser comorbidity index), length of stay, admission, and hospital characteristics (location and teaching status) were accounted for in our multivariable regression analysis.

Statistical analysis
--------------------

To compare the demographic characteristics, covariates, and other outcomes of interest among our study groups, we performed bivariate analysis and used Pearson's chi-squared tests. We calculated two-tailed *p*-values and defined statistical significance as *p*-value less than 0.05. We adjusted for the pertinent demographics and confounders by performing a multivariable regression analysis.

To calculate the burden of comorbidities, we utilized the software provided by the HCUP and generated the Elixhauser index from the ICD-9-CM diagnosis codes \[[@b12-ce-2019-094],[@b13-ce-2019-094]\]. The mean length of stay and hospital cost were calculated for each month. All statistical analyses were performed using IBM SPSS Statistics for Windows, version 25.0 (IBM Co., Armonk, NY, USA).

RESULTS
=======

Demographics
------------

Between 2005 and 2014, a total of 348,958 cases with esophageal variceal hemorrhage were identified and included in the study sample. The mean age of the entire cohort was 55.7 years, with the 51--65-year age group constituting approximately half (48.3%) of all hospitalizations. Men comprised 69.1% of cases, with the most common race being White (62.3%), followed by Hispanic (22.3%), and Black (7.7%). Almost 90% of all acute variceal hemorrhage hospitalizations were in urban hospital settings, with 40% in urban non-teaching hospitals and 50% in urban teaching hospitals.

Hospitalization volume
----------------------

The highest number of variceal hemorrhage-related admissions was reported in December (*n*=30,786; 8.8%), followed by March (*n*=30,492; 8.7%) and January (*n*=30,404; 8.7%). The lowest number of admissions was reported in June (27,247; 7.8%). [Table 1](#t1-ce-2019-094){ref-type="table"} summarizes the total number of hospitalizations for each month. We further compared the months based on per-day hospitalizations, as summarized in [Table 2](#t2-ce-2019-094){ref-type="table"} and [Fig. 2](#f2-ce-2019-094){ref-type="fig"}. June (90.8 admissions per day) had the fewest number of hospitalizations for esophageal varices hemorrhage in contrast to December (99.3 admissions per day), which had the highest daily admission rate.

Mortality
---------

The overall in-hospital mortality is displayed in [Table 1](#t1-ce-2019-094){ref-type="table"} and a graphical presentation is shown in [Fig. 3](#f3-ce-2019-094){ref-type="fig"}. The lowest and highest in-hospital mortality rates occurred in June (9.8 %) and January (11.5%), respectively. We further compared the in-hospital mortality for each month by adjusting for various confounding factors between each month and calculated the adjusted odds ratios (ORs) with June as the reference month. After adjusting for the confounding effects of age, sex, race, comorbidities (Elixhauser comorbidity index), length of stay, elective/non-elective admission status, and hospital characteristics (hospital location and teaching status), we assessed mortality rates and calculated the adjusted OR. The adjusted mortality was highest in January (overall morality = 11.5%, adjusted OR, 1.268; 95% confidence interval, 1.194--1.345; *p*\<0.0001) and lowest in June (overall mortality rate = 9.8%). The results of the multivariable regression analysis are summarized in [Table 3](#t3-ce-2019-094){ref-type="table"}.

US regional analysis
--------------------

The results of our regional analysis showed that the overall rates of hospitalization for acute variceal hemorrhage were relatively higher in hospitals located in the South, followed by those in the West, Midwest, and Northeast. [Fig. 4](#f4-ce-2019-094){ref-type="fig"} shows a graphical presentation of these regional differences. Across all four geographical areas, we noted a relative decrease in variceal hemorrhage-related hospitalizations in June. We also noted relatively higher hospitalization rates in the winter months in all regions; however, the Midwest region showed the highest admission rates in the fall months. All-cause in-hospital mortality associated with esophageal variceal bleeding for each region is summarized in [Table 3](#t3-ce-2019-094){ref-type="table"}. In-hospital mortality remained relatively higher in winter months across all geographical regions.

Health care resource utilization
--------------------------------

The mean length of stay for the entire cohort was 6.35 days (6.21--6.46 days) and the average total hospitalization cost was \$17,123. We did not find substantial differences in hospital lengths of stay or hospital costs across the various months ([Table 4](#t4-ce-2019-094){ref-type="table"}). The highest number of esophagogastroduodenoscopy (EGD) procedures for variceal hemorrhage was performed in December (*n*=25,940), 77.5% (*n*=20,129) of which involved endoscopic therapy for hemostasis. The fewest EGD procedures were performed in June (*n*=22,849), 75.1% (*n*=17,176) of which involved endoscopic therapy for hemostasis. We also noted that the overall in-hospital mortality for the patients undergoing EGD was 8.2%, which was lower than that in patients who did not undergo EGD (21.5%).

DISCUSSION
==========

We utilized the largest all-payer inpatient database to evaluate whether seasonal variation existed for hospitalizations and outcomes associated with esophageal variceal hemorrhage over a ten-year period. We found a significant month to month difference in the rate of esophageal variceal bleeding-related hospitalizations. Both the monthly volume of hospitalizations and per-day admission rates were higher for December than those for June. We also observed comparable differences in mortality rates. However, hospital costs and length of stay associated with each admission remained relatively similar for each month.

Seasonal variation in acute upper gastrointestinal hemorrhage has been previously described in North America and Europe. However, there is lack of consensus regarding the importance of these findings. While several studies observed seasonal variation in upper gastrointestinal bleeding \[[@b7-ce-2019-094]-[@b10-ce-2019-094],[@b14-ce-2019-094]-[@b16-ce-2019-094]\], others did not \[[@b17-ce-2019-094]-[@b19-ce-2019-094]\]. Boulay et al. specifically studied seasonal variation in esophageal variceal bleeding by utilizing a French public hospital database \[[@b15-ce-2019-094]\]. They observed that both hospitalizations and mortality from esophageal varices hemorrhage peaked in winter, specifically in December \[[@b15-ce-2019-094]\]. A similar study by Yen et al. from Taiwan found that the occurrence of esophageal varices hemorrhage peaked in February \[[@b14-ce-2019-094]\]. Kanotra et al. utilized the United States NIS database to assess the seasonal variation in peptic ulcer disease \[[@b20-ce-2019-094]\]. They found that the admission rate peaked in February \[[@b20-ce-2019-094]\]. To our knowledge, the current study is the first to assess the seasonal pattern in esophageal variceal hemorrhage at a national scale within the United States.

Advances in endoscopic therapy and intensive screening for esophageal varices have led to significant reduction in the overall mortality associated with esophageal variceal hemorrhage over the last several decades \[[@b3-ce-2019-094],[@b6-ce-2019-094],[@b21-ce-2019-094],[@b22-ce-2019-094]\]. However, esophageal variceal bleeding continues to have a higher mortality rate compared to the rates for other causes of upper gastrointestinal bleeding \[[@b11-ce-2019-094]\]. It is important to analyze whether environmental factors related to changes of season contribute to the observed epidemiology of esophageal variceal bleeding. Indepth understanding of this disease pattern can help clinicians redirect their resources, which can ultimately lead to an improvement in healthcare delivery.

Several authors have hypothesized that the seasonal variation in upper gastrointestinal hemorrhage is at least partially secondary to seasonal fluctuations in the use of non-steroidal anti-inflammatory drugs (NSAIDs) \[[@b9-ce-2019-094]\]. NSAIDs are a well-known cause for esophageal variceal bleeding \[[@b23-ce-2019-094]\]. Therefore, increased use of NSAIDs in winter months could predispose or increased the risk of hemorrhage from esophageal varices. A recently published study by Ventura-Cots et al. found that alcohol use increased in winter months, which increased the burden of alcohol-associated liver diseases \[[@b24-ce-2019-094]\]. Their study also noted that both lower temperatures and decreased sunshine hours were correlated with increased alcohol consumption \[[@b24-ce-2019-094]\]. Relatively lower temperatures cause peripheral vasoconstriction; therefore, increased portal blood flow could perhaps be attributed to this physiological change. Budzyński et al. did not find any correlation between seasonal changes in the upper gastrointestinal hemorrhage and changes in atmospheric pressure \[[@b18-ce-2019-094]\]. It is also possible that single or multiple unknown epidemiological or clinical factors may be impacting the incidence of gastrointestinal bleeding in general and variceal bleeding in particular.

Our study has several limitations. This observational study relied on a large nationwide database. Therefore, individual chart review was not possible. The accuracy of analysis depended upon the ICD 9 codes entered at the time of hospitalization. However, ICD codes have high diagnostic and procedural accuracies for outcome research related to upper gastrointestinal hemorrhage \[[@b25-ce-2019-094]\]. Despite these limitations, the strength of the study lies in the breadth of the data which involved all hospitalizations over a decade. The use of a nationwide database eliminates the bias generated from single-center or even smaller multi-center studies. Our findings suggest the need for further studies to more fully identify seasonal variations related to particular geographical regions.

There are seasonal variations in hospitalizations related to esophageal variceal hemorrhage across the United States. The effect of variation in environmental and patient-specific triggers across various seasons and their impact on esophageal variceal hemorrhage requires further exploration.
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###### 

Monthly Incidence and In-Hospital Mortality Associated with Esophageal Variceal Hemorrhage

  Admission month   Outcome   Total     
  ----------------- --------- --------- ---------
  January           3,488     26,916    30,404
  February          2,915     24,896    27,811
  March             3,348     27,144    30,492
  April             2,858     25,920    28,778
  May               2,943     26,603    29,546
  June              2,665     24,582    27,247
  July              2,965     25,659    28,624
  August            2,949     26,017    28,966
  September         2,837     24,930    27,767
  October           3,021     26,588    29,609
  November          3,263     25,665    28,928
  December          3,174     27,612    30,786
  Total             36,426    312,532   348,958

###### 

Adjusted Odds Ratios for In-Hospital Mortality

  Month       Adjusted odds ratio   95% confidence interval for adjusted odds ratio   *p*-value   
  ----------- --------------------- ------------------------------------------------- ----------- -----------
  January     1.268                 1.194                                             1.345       0.001
  February    1.147                 1.079                                             1.220       0.001
  March       1.197                 1.128                                             1.271       0.001
  April       1.098                 1.032                                             1.168       0.003
  May         1.022                 0.961                                             1.087       0.490
  June        1.000                 Reference                                         Reference   Reference
  July        1.067                 1.003                                             1.135       0.038
  August      1.082                 1.017                                             1.150       0.012
  September   1.096                 1.030                                             1.166       0.004
  October     1.086                 1.022                                             1.155       0.008
  November    1.184                 1.114                                             1.257       0.001
  December    1.101                 1.037                                             1.170       0.002

###### 

In-Hospital Mortality (%) for Each Month according to Geographical Region

  Month       Northeast   Midwest   South   West
  ----------- ----------- --------- ------- ------
  January     14.5        11.7      10.6    11.5
  February    12.1        9.7       9.9     10.5
  March       11.4        9.6       11.3    11
  April       12.2        9.6       8.8     9.9
  May         12.5        10.4      9.1     10
  June        13          10        9.7     9.8
  July        12          11        10.8    10.4
  August      13.2        9.7       8.5     10.2
  September   10.6        9.4       10.5    10.2
  October     12.9        10.3      8.8     10.2
  November    13.3        10.3      11      11.3
  December    13          9.9       9.8     10.3

###### 

Mean Hospital Costs and Length of Stay for Each Month

  Month       Mean     
  ----------- -------- ------
  January     17,404   6.44
  February    16,834   6.45
  March       17,006   6.35
  April       16,948   6.31
  May         16,458   6.27
  June        17,285   6.37
  July        17,579   6.38
  August      17,000   6.21
  September   17,211   6.36
  October     16,984   6.26
  November    17,541   6.46
  December    17,244   6.37
  Overall     17,123   6.35
